68 related articles for article (PubMed ID: 17445464)
1. [Challenge and up-to-date of molecule target therapy in lung cancer].
Han BH
Zhonghua Jie He He Hu Xi Za Zhi; 2007 Feb; 30(2):83-5. PubMed ID: 17445464
[No Abstract] [Full Text] [Related]
2. Targeted therapy for non-small cell lung cancer.
Toloza EM; D'Amico TA
Semin Thorac Cardiovasc Surg; 2005; 17(3):199-204. PubMed ID: 16253823
[TBL] [Abstract][Full Text] [Related]
3. Angiogenesis inhibitors in the treatment of small cell and non-small cell lung cancer.
Blackhall FH; Shepherd FA
Hematol Oncol Clin North Am; 2004 Oct; 18(5):1121-41, ix. PubMed ID: 15474338
[TBL] [Abstract][Full Text] [Related]
4. Advances in target therapy for lung cancer.
Mitsudomi T
Jpn J Clin Oncol; 2010 Feb; 40(2):101-6. PubMed ID: 20031962
[TBL] [Abstract][Full Text] [Related]
5. Signal transduction pathways as novel therapy targets in lung cancer.
Reinmuth N; Mesters RM; Bieker R; Hoffknecht P; Berdel WE; Thomas M
Lung Cancer; 2004 Aug; 45 Suppl 2():S177-86. PubMed ID: 15552798
[TBL] [Abstract][Full Text] [Related]
6. A selective small molecule inhibitor of c-Met, PHA665752, inhibits tumorigenicity and angiogenesis in mouse lung cancer xenografts.
Puri N; Khramtsov A; Ahmed S; Nallasura V; Hetzel JT; Jagadeeswaran R; Karczmar G; Salgia R
Cancer Res; 2007 Apr; 67(8):3529-34. PubMed ID: 17440059
[TBL] [Abstract][Full Text] [Related]
7. COX-2 inhibitor as a radiation enhancer: new strategies for the treatment of lung cancer.
Saha D; Pyo H; Choy H
Am J Clin Oncol; 2003 Aug; 26(4):S70-4. PubMed ID: 12902860
[TBL] [Abstract][Full Text] [Related]
8. [Role of radiation therapy in the treatment of patients with small cell lung cancer].
Kiseleva ES; Dar'ialova SL; Boĭko AV; Zvekotkina LS
Vopr Onkol; 1985; 31(10):55-61. PubMed ID: 2998091
[TBL] [Abstract][Full Text] [Related]
9. A phase II study of induction chemotherapy followed by concurrent chemoradiotherapy in elderly patients with locally advanced non-small-cell lung cancer.
Giorgio CG; Pappalardo A; Russo A; Santini D; Di Rosa C; Di Salvo C; Castorina S; Marletta F; Bellissima G; Palermo N; Scuderi C; Bordonaro R
Anticancer Drugs; 2007 Jul; 18(6):713-9. PubMed ID: 17762402
[TBL] [Abstract][Full Text] [Related]
10. Vascular endothelial growth factor trap in non small cell lung cancer.
Riely GJ; Miller VA
Clin Cancer Res; 2007 Aug; 13(15 Pt 2):s4623-7. PubMed ID: 17671153
[TBL] [Abstract][Full Text] [Related]
11. Multitargeted inhibitors in lung cancer: new clinical data.
Bar J; Herbst RS; Onn A
Clin Lung Cancer; 2008; 9 Suppl 3():S92-9. PubMed ID: 19419930
[TBL] [Abstract][Full Text] [Related]
12. The role of targeted agents in adjuvant therapy for non-small cell lung cancer.
Kelly K
Clin Cancer Res; 2005 Jul; 11(13 Pt 2):5027s-5029s. PubMed ID: 16000608
[TBL] [Abstract][Full Text] [Related]
13. Advances in the biology of lung cancer chemoprevention.
Hirsch FR; Lippman SM
J Clin Oncol; 2005 May; 23(14):3186-97. PubMed ID: 15886305
[TBL] [Abstract][Full Text] [Related]
14. [A case of lung and pleural metastases from breast cancer responding to toremifene].
Inoue K; Tabei T; Kusawake T; Sugamata N; Suemasu K; Higashi Y; Kurosumi M
Gan To Kagaku Ryoho; 2001 Feb; 28(2):221-4. PubMed ID: 11242650
[TBL] [Abstract][Full Text] [Related]
15. Peroxisome proliferator-activated receptor delta as a molecular target to regulate lung cancer cell growth.
Fukumoto K; Yano Y; Virgona N; Hagiwara H; Sato H; Senba H; Suzuki K; Asano R; Yamada K; Yano T
FEBS Lett; 2005 Jul; 579(17):3829-36. PubMed ID: 15978581
[TBL] [Abstract][Full Text] [Related]
16. Treatment of metastatic non-small-cell lung cancer.
Johnson DH; Sandler A
Chest Surg Clin N Am; 2001 Feb; 11(1):133-64. PubMed ID: 11253595
[TBL] [Abstract][Full Text] [Related]
17. Selective inhibition of fatty acid synthase for lung cancer treatment.
Orita H; Coulter J; Lemmon C; Tully E; Vadlamudi A; Medghalchi SM; Kuhajda FP; Gabrielson E
Clin Cancer Res; 2007 Dec; 13(23):7139-45. PubMed ID: 18056164
[TBL] [Abstract][Full Text] [Related]
18. [Small-cell lung cancer].
Yablonski-Peretz Y; Halpern J; Sulkes A; Fuks Z; Catane R
Harefuah; 1984 May; 106(10):450-3. PubMed ID: 6088373
[No Abstract] [Full Text] [Related]
19. Oncogenic mutation of PIK3CA in small cell lung carcinoma: a potential therapeutic target pathway for chemotherapy-resistant lung cancer.
Shibata T; Kokubu A; Tsuta K; Hirohashi S
Cancer Lett; 2009 Oct; 283(2):203-11. PubMed ID: 19394761
[TBL] [Abstract][Full Text] [Related]
20. Incorporating bortezomib into the treatment of lung cancer.
Davies AM; Lara PN; Mack PC; Gandara DR
Clin Cancer Res; 2007 Aug; 13(15 Pt 2):s4647-51. PubMed ID: 17671158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
